NEW YORK (GenomeWeb News) - Pacific Biosciences said today that it has raised $100 million in new financing that it will use to commercially develop its single-molecule DNA sequencing platform.
Hugh Martin, chairman and CEO of Pacific Biosciences, said in a statement that the financing “will enable us to surge forward with an aggressive development program” and commercialize the platform in 2010.
The Series E private equity funding came from a group composed of both new previous investors.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.